25Serious

Marie Benoît

Ask VT AI

View News Summary

Gilead Sciences reports strong Q2 results, raises full-year guidance, and sees shares rise on the back of its HIV portfolio and new drug launches.
Israel plans to occupy Gaza City, disarm Hamas, and transfer control to Arab forces, despite concerns over humanitarian risks and hostage lives.
Krispy Kreme reports massive Q2 loss, triggering a turnaround plan focused on cost reduction and operational efficiency.

20 hours

United States Politics

Discover the latest news, candidates,  and key topics of US politics

Ask VT AI

View News Summary

Gilead Sciences reports strong Q2 results, raises full-year guidance, and sees shares rise on the back of its HIV portfolio and new drug launches.
Israel plans to occupy Gaza City, disarm Hamas, and transfer control to Arab forces, despite concerns over humanitarian risks and hostage lives.
Krispy Kreme reports massive Q2 loss, triggering a turnaround plan focused on cost reduction and operational efficiency.

20 hours

United States Politics

Discover the latest news, candidates,  and key topics of US politics

Most Reported By
News from Marie Benoît